“…A common feature of Ligurian and Kattegat krill was the inhibition of PKI and PKII by ATP and the activation of PKII by fructose-1,6-bisphosphate (FBP), a key metabolite in the glycolytic pathway. Moreover, in the presence of FBP, the sigmoidal kinetics of PKII was shifted to hyperbolic kinetics (Vetter and Buchholz, 1997). Differences were apparent in the share of both isoforms in whole body extracts: PKI amounted to 80% in Ligurian krill, but only 44% in Kattegat krill.…”